Ampio Pharmaceuticals Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch AMPE and buy or sell other stocks, ETFs, and their options commission-free!

About AMPE

Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. 

CEO
Michael A. Martino, MBA
CEOMichael A. Martino, MBA
Employees
21
Employees21
Headquarters
Englewood, Colorado
HeadquartersEnglewood, Colorado
Founded
2008
Founded2008
Employees
21
Employees21

AMPE Key Statistics

Market cap
2.76M
Market cap2.76M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
182.03K
Average volume182.03K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.60
52 Week high$0.60
52 Week low
$0.199
52 Week low$0.199

Stock Snapshot

As of today, Ampio Pharmaceuticals Inc.(AMPE) shares are valued at $0.18. The company's market cap stands at 2.76M.

During the trading day, Ampio Pharmaceuticals Inc.(AMPE) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 182.03K.

The stock's 52-week range extends from a low of $0.20 to a high of $0.60.

The stock's 52-week range extends from a low of $0.20 to a high of $0.60.

People also own

Based on the portfolios of people who own AMPE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.